Healthcare Cold Chain Logistics Market is likely to grow from USD 197.7 bn in 2024 to USD 207.0 bn in 2025 and USD 320.9 bn by 2035, representing a CAGR of 4.5%

In 2020, the global healthcare cold chain logistics market was sized at **** billion U.S. dollars. Over the upcoming years, this market is expected to expand in size. By 2026, the global healthcare cold chain logistics market is forecasted to reach **** billion U.S. dollars.

The Healthcare Cold Chain Logistics Market Report is Segmented by Service Type (Storage, Transportation, and More), Product Type (Vaccines, Biopharmaceuticals, and More), Temperature Range (Controlled Ambient 15–25°C, and More), Transportation Mode (Air Freight, and More), End User (Pharmaceutical & Biotech, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Market Research Intellect's Healthcare Cold Chain Logistics Market Report highlights a valuation of USD 17.6 billion in 2024 and anticipates growth to USD 30.2 billion by 2033, with a CAGR of 7.4% from 2026-2033.Explore insights on demand dynamics, innovation pipelines, and competitive landscapes.

The Europe Healthcare Cold Chain Logistics Market report segments the industry into By Product (Biopharmaceuticals, Vaccines, Clinical Trial Materials), By Services (Transportation, Storage, Value Added Services (Packaging and Labeling)), By End User (Hospitals, Clinics and Pharmaceuticals, Biopharmaceutical, Biotechnology) and By Country (Germany, France, Spain, Rest of Europe). Get five years of historical data and forecasts.

The European healthcare cold chain logistics market is experiencing robust growth, projected to reach €10.40 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 9.69% from 2025 to 2033. This expansion is driven by several key factors. The increasing prevalence of chronic diseases necessitates the efficient and reliable transportation and storage of temperature-sensitive pharmaceuticals, including biopharmaceuticals and vaccines. Furthermore, the rising demand for personalized medicine and advanced therapies, often requiring stringent cold chain management, fuels market growth. Stringent regulatory requirements concerning product safety and efficacy further incentivize investment in sophisticated cold chain logistics solutions. The market is segmented by product type (biopharmaceuticals, vaccines, clinical trial materials), service type (transportation, storage, value-added services like packaging and labeling), and end-user (hospitals, clinics, pharmaceutical and biotechnology companies). Leading market players include DB Schenker, DHL, Marken Ltd., and others, competing based on their network reach, technological capabilities, and specialized services. The focus is shifting towards advanced technologies such as real-time monitoring, IoT-enabled solutions, and data analytics to enhance supply chain visibility and ensure product integrity throughout the cold chain. This technological advancement is expected to drive further growth in the coming years. The geographical focus is heavily concentrated on major European economies. Within Europe, the United Kingdom, Germany, France, and other countries contribute significantly to market revenue. However, opportunities exist for expansion into smaller markets as healthcare infrastructure improves and demand for specialized cold chain logistics increases across the region. Challenges remain, such as managing the complexities of cross-border regulations and ensuring cost-effectiveness while maintaining the highest standards of product integrity. The market's continued growth hinges on overcoming these challenges through collaboration across the supply chain and leveraging technological innovations to enhance efficiency and reduce risks. This ongoing innovation, coupled with increasing demand for temperature-sensitive healthcare products, ensures the long-term potential of the European healthcare cold chain logistics market. Key drivers for this market are: Increasing Focus on Vaccine Distribution, Growing Pharmaceutical and Biotechnology Industries. Potential restraints include: High Initial Capital Investment, Risk of Temperature Excursions. Notable trends are: The OTC Pharmaceuticals Consumption is Projected to Grow Significantly.

The global healthcare cold chain logistics market was valued at USD 20.39 billion in 2022 and is expected to reach USD 27.74 billion by 2028, growing at a CAGR of 5.26%.

The Asia Pacific Healthcare Cold Chain Logistics Market Report is Segmented by Services (Transportation, Warehousing and Distribution, Value-Added Services and Others), Temperature Type (Chilled, and More), Product (Biopharmaceuticals, Vaccines and Cell & Gene Therapies, and More), End User (Pharmaceutical Manufacturers, and More), and Geography (China, Japan, and More). The Market Forecasts are Provided in Terms of Value (USD).

Healthcare Cold Chain Logistics Market Outlook

According to our latest research, the global healthcare cold chain logistics market size reached USD 22.1 billion in 2024, driven by the increasing demand for temperature-sensitive pharmaceutical products and biologics across the globe. The market is projected to grow at a robust CAGR of 8.4% during the forecast period, reaching a value of USD 45.9 billion by 2033. The primary growth factor for this market is the rising prevalence of chronic diseases, which necessitates the efficient and safe transportation of vaccines, biopharmaceuticals, and clinical trial materials under stringent temperature-controlled environments.

The growth of the healthcare cold chain logistics market is underpinned by the rapid expansion of the global pharmaceutical sector, particularly in emerging economies. With increasing investments in research and development, pharmaceutical companies are launching a greater number of biologics and specialty drugs that require precise temperature management throughout the supply chain. These advancements have made cold chain logistics indispensable in ensuring product efficacy and safety, as even minor temperature deviations can compromise the quality of sensitive healthcare products. Moreover, the rise in global vaccination campaigns, especially in response to pandemics and infectious diseases, is further fueling demand for reliable cold chain solutions.

Technological innovations are another critical driver for the healthcare cold chain logistics market. The integration of IoT, RFID, and real-time temperature monitoring systems has revolutionized the industry, enabling end-to-end visibility and proactive risk management. These technologies help logistics providers maintain compliance with regulatory standards and minimize product loss due to temperature excursions. Additionally, the increasing adoption of automation and advanced packaging materials has enhanced the efficiency and reliability of cold chain operations, reducing operational costs while ensuring product integrity. The trend toward digitalization and data-driven decision-making is expected to continue shaping the market landscape in the coming years.

The market is also witnessing a significant shift toward sustainability, as stakeholders seek to minimize the environmental impact of cold chain operations. The adoption of energy-efficient refrigeration systems, eco-friendly packaging, and alternative fuels for transportation are becoming increasingly prevalent. Regulations aimed at reducing carbon emissions and improving environmental stewardship are prompting logistics providers to invest in greener solutions. This focus on sustainability not only aligns with global environmental goals but also enhances brand reputation and meets the growing expectations of healthcare companies and consumers alike.

Regionally, North America remains the largest market for healthcare cold chain logistics, attributed to its advanced healthcare infrastructure, high pharmaceutical production, and stringent regulatory standards. However, Asia Pacific is emerging as the fastest-growing region, driven by expanding pharmaceutical manufacturing, increasing healthcare spending, and rising demand for temperature-sensitive products. Europe also holds a significant share, supported by well-established logistics networks and robust government initiatives to ensure vaccine and biopharmaceutical safety. Meanwhile, Latin America and the Middle East & Africa are experiencing steady growth as healthcare systems modernize and access to advanced therapies improves.

Service Type Analysis

The healthcare cold chain logistics market is segmented by service type into storage, transportation, packaging, and others. Storage services play a critical role in maintaining the required temperature conditions for pharmaceuticals, vaccines, and other biologics throughout the supply chain. The demand for specialized cold storage facilities is growing rapidly, driven by the increasing co

Healthcare Cold Chain Logistics Market size was valued at USD 210.4 Billion in 2024 and is projected to reach USD 294.18 Billion by 2032, growing at a CAGR of 4.72% from 2026 to 2032.Rising Demand for Temperature Sensitive Pharmaceuticals, Vaccines, and Biologics: The surging demand for temperature sensitive pharmaceuticals, vaccines, and biologics is arguably the most significant catalyst for the cold chain logistics market. Modern medicine increasingly relies on complex biological compounds, such as protein based drugs, insulins, and advanced vaccines, which are highly susceptible to temperature fluctuations.Growth in Global Clinical Trials and Increasing Distribution of Biopharmaceuticals: The expansion of global clinical trials and the increasing distribution of biopharmaceuticals are profoundly impacting the healthcare cold chain logistics landscape.

The South Korea healthcare cold chain logistics market size reached USD 302.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 852.2 Million by 2033, exhibiting a growth rate (CAGR) of 11.2% during 2025-2033.

IMARC Group provides an analysis of the key trends in each sub-segment of the South Korea healthcare cold chain logistics market report, along with forecasts at the country and regional levels from 2025-2033. Our report has categorized the market based on product and segment.

The global healthcare cold chain logistics market was valued at USD 57.18 Billion in 2024 and is expected to grow at a CAGR of 9.30%, reaching USD 139.14 Billion by 2034. The market growth is supported by the increasing demand for temperature-sensitive pharmaceuticals and vaccines, along with advancements in real-time monitoring and tracking technologies. Growing investments in cold storage infrastructure and expansion of distribution networks are enhancing efficiency and reliability. Rising focus on regulatory compliance and the expansion of biologics and personalized medicines are also expected to drive market growth in the forecast period.

Key Market Trends and Insights

• Based on service type, the transportation segment led the market during the historical period.
• By product type, the biopharmaceuticals segment held a dominant position during the historical period.
• North America accounted for nearly 30% of the market share in the historical period.

Market Size and Forecast

• Market Size (2024): USD 57.18 Billion
• Projected Market Size (2034): USD 139.14 Billion
• CAGR (2025-2034): 9.30%

The size of the Healthcare Cold Chain Logistics Market was valued at USD 15.6 billion in 2023 and is projected to reach USD 28.90 billion by 2032, with an expected CAGR of 9.21% during the forecast period. Recent developments include: January 2021: Varcode has collaborated with PL Development. The partnerships are expected to improve supply cold chain logistics efficiency, particularly in the healthcare sector., December 2020: FedEx Corp. purchased ShopRunner. The acquisition will improve e-commerce capabilities by providing the cost-effective healthcare cold chain logistics required to provide biopharmaceutical products on time., March 2020: CEVA Logistics has introduced a new healthcare sub-brand called CEVA FORPATIENTS. The cold chain logistics under this brand will only be used for medical needs, including the delivery of medications and the transfer of organs.. Key drivers for this market are: GROWING TRANSPORTATION OF TEMPERATURE-SENSITIVE PHARMACEUTICAL PRODUCTS VIA COLD CHAIN LOGISTICS, GROWING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS; INCREASING NUMBER OF CLINICAL TRIALS. Potential restraints include: DIFFICULTY TO ACCESS DIFFERENT MARKETS, FAILURE TO COMPLY WITH THE REGULATORY STANDARDS. Notable trends are: Rising transportation of temperature-sensitive pharmaceuticals via cold chain logistics to drive market growth.

Snapshot img

Cold Chain Logistics Market For Pharmaceuticals Industry Size 2025-2029

The cold chain logistics market for pharmaceuticals industry size is forecast to increase by USD 14.56 billion at a CAGR of 9.9% between 2024 and 2029.

The cold chain logistics market for the pharmaceuticals industry is experiencing significant growth due to the increasing demand for biopharmaceuticals and consumer healthcare products. The consolidation In the global healthcare logistics industry is driving market expansion, with third-party logistics providers increasingly offering specialized services in cold chain logistics. However, functional barriers in cold chain logistics, such as the need for specialized real estate, HVAC systems, and insulated containers, increase operational costs. Advancements in technology are playing a crucial role in mitigating these challenges. For instance, the implementation of blockchain technology in pharmaceutical logistics enhances traceability and security, ensuring the integrity of temperature-sensitive pharmaceuticals like vaccines and insulin during transportation.Furthermore, software solutions utilizing predictive analytics and machine learning enable efficient monitoring of cold chain conditions and proactive intervention in case of deviations. In the realm of freight logistics, air freight remains the preferred mode for transporting temperature-sensitive pharmaceuticals due to its speed and ability to maintain consistent temperatures. However, the high cost of air freight is a significant challenge, necessitating the optimization of packaging and labeling to minimize damage and reduce wastage. In conclusion, the cold chain logistics market for pharmaceuticals is poised for growth, driven by the increasing demand for temperature-sensitive pharmaceuticals and advancements in technology.However, challenges such as high operational costs and the need for specialized infrastructure persist, necessitating continuous innovation and collaboration between stakeholders to ensure the efficient and effective delivery of these vital products.

What will be the Size of the Cold Chain Logistics Market For Pharmaceuticals Industry during the forecast period?

Request Free SampleThe cold chain logistics market for the pharmaceutical industry is a critical sector ensuring the integrity and efficacy of temperature-sensitive pharmaceutical products, including novel drugs, vaccines, biopharmaceuticals, clinical trial materials, and over-the-counter medicines. This market encompasses various stages from transportation in refrigerated or frozen conditions to storage in specialized facilities, labeling, last-mile delivery, and distribution to hospitals & clinics. The market's size is substantial, driven by the increasing demand for temperature-controlled logistics due to the growing number of temperature-sensitive pharmaceutical products. Refrigerated temperature, frozen temperature, and cryogenic temperature logistics are essential for maintaining the efficacy of these products. Key trends include the implementation of advanced technologies like telematics for real-time temperature monitoring and improved supply chain visibility.Sea freight logistics, air freight logistics, and overland logistics are used for transportation, with hubs-to-distributor models optimizing distribution networks. Ambient temperature logistics also play a role In the pharmaceutical supply chain, but the demand for cold chain logistics is expected to continue growing due to the increasing prevalence of temperature-sensitive pharmaceuticals.

How is this Cold Chain Logistics For Pharmaceuticals Industry Industry segmented?

The cold chain logistics for pharmaceuticals industry industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductVaccinesBiopharmaceuticalsClinical trial materialsServiceWarehousing and VASTransportationMode of DeliveryLast-Mile DeliveryHubs-to-DistributorTemperature RangeAmbientRefrigeratedFrozenCryogenicEnd UserHospitals & ClinicsPharmaceuticalBiopharmaceuticalBiotechnology CompaniesOthersGeographyAPACChinaIndiaJapanSouth KoreaNorth AmericaCanadaUSEuropeGermanyUKFranceSouth AmericaBrazilMiddle East and Africa

By Product Insights

The vaccines segment is estimated to witness significant growth during the forecast period.The pharmaceutical industry's reliance on cold chain logistics has grown significantly due to the increasing development and export of temperature-sensitive goods, including novel drugs, vaccines, and biopharmaceuticals. Cold chain logistics ensures the proper transportation, storage, labeling, and last-mile delivery of these goods at specific temperatures - ambient, refrigerated, frozen, or cryogenic. With the rise of advanced technologies like telematics, machine learning, b

The size of the Air Freight Healthcare Cold Chain Logistics market was valued at USD XXX million in 2023 and is projected to reach USD XXX million by 2032, with an expected CAGR of XX% during the forecast period.

The global healthcare cold chain logistics market, valued at approximately $19.05 billion in 2025, is experiencing robust growth driven by the increasing demand for temperature-sensitive pharmaceutical products, including vaccines, biologics, and other specialized medications. This surge is fueled by factors such as the rising prevalence of chronic diseases, advancements in biotechnology leading to more temperature-sensitive therapies, and the expansion of global healthcare infrastructure, particularly in emerging economies. Stringent regulatory requirements regarding the storage and transportation of these products further underpin market expansion. Significant investments in advanced cold chain technologies, such as temperature-controlled containers, monitoring devices, and sophisticated logistics management systems, are enhancing efficiency and reliability across the supply chain, mitigating risks associated with product spoilage or degradation. However, maintaining the integrity of the cold chain presents considerable challenges. Fluctuations in fuel prices, geopolitical instability impacting transportation routes, and the need for robust infrastructure development, especially in less developed regions, pose significant restraints. Furthermore, the increasing complexity of the healthcare supply chain necessitates sophisticated management systems and technological integration to ensure effective tracking, monitoring, and data analysis. The market is segmented by various factors, including transportation mode (air, sea, road), storage type (refrigerated warehouses, cold rooms), and product type (vaccines, biologics, pharmaceuticals). Key players such as Americold Logistics, Lineage Logistics, and DHL are investing heavily in expanding their capabilities to meet the growing demand and maintain their competitive edge. The market is expected to continue its upward trajectory, driven by ongoing innovation and the increasing focus on patient safety and access to life-saving medications. Growth will likely be uneven across regions, with developed markets already exhibiting high adoption rates while emerging markets present significant growth opportunities.

In North America Healthcare Cold Chain Logistics Market, UPS Healthcare is expanding its activities in the Benelux region by announcing the debut of a new ground transportation service for cold chain products.

In 2024, Market Research Intellect valued the Air Freight Healthcare Cold Chain Logistics Market Report at USD 6.2 billion, with expectations to reach USD 10.5 billion by 2033 at a CAGR of 7.4%.Understand drivers of market demand, strategic innovations, and the role of top competitors.

Snapshot img

What is the Size of UK Cold Chain Logistics Market?

The UK cold chain logistics market size is forecast to increase by USD 8.50 billion, at a CAGR of 9.9% between 2024 and 2029. The market is experiencing significant growth due to several key trends and challenges. One major trend driving market growth is the increasing use of RFID technology and IoT solutions in cold chain logistics to enhance supply chain visibility and improve efficiency. Another trend is the growing demand for technological advancements to address poor customer satisfaction and ensure the timely delivery of temperature-sensitive goods. However, the market also faces challenges such as high operational costs and the need for specialized infrastructure to maintain the required temperature conditions. To mitigate these challenges, market players are investing in advanced technologies and partnerships to improve their offerings and gain a competitive edge. Overall, the market is expected to witness strong growth in the coming years as businesses prioritize the secure and efficient transportation of temperature-sensitive goods.

Request Free Market Sample

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019 - 2022 for the following segments.

Application

  MFS
  Dairy and frozen desserts
  FVB
  Others


Type

  Refrigerated warehouse
  Refrigerated transportation


Geography

  UK

Which is the largest segment driving market growth?

The MFS segment is estimated to witness significant growth during the forecast period. Cold chain logistics plays a crucial role in preserving the quality and nutritional value of perishable goods, including meat, fish, and seafood. These foods have specific temperature requirements for storage to maintain their freshness and prevent spoilage. For instance, fresh seafood must be kept at a temperature of 32 degrees F (0 degrees C), while frozen seafood requires storage at 0.40 degrees F (-18 degrees C) or below. These ogistics solutions ensure these temperature requirements are met, thereby preserving the quality of these goods. Online grocery delivery services have gained significant traction in the US market, driving the demand for this logistics. This trend is further fueled by the increasing popularity of e-commerce platforms for purchasing dairy products, fruits and vegetables, and vaccines and biologics.

Get a glance at the market share of various regions. Download the PDF Sample

The MFS segment was valued at USD 3.87 billion in 2019. Digitalization is transforming the cold chain logistics industry, enabling real-time temperature monitoring and automated tracking systems. Cold chain logistics is also essential for the successful implementation of vaccination campaigns. Vaccines and biologics require precise temperature control to maintain their efficacy, making this logistics a critical component of healthcare supply chains. The globalization of markets and the increasing demand for fresh produce and perishable goods have led to the expansion of these logistics networks. The use of advanced temperature monitoring devices and technologies, such as GPS and IoT, enables real-time monitoring and tracking of goods, ensuring their quality and safety. In conclusion, this logistics plays a vital role in preserving the quality and nutritional value of perishable goods, including meat, fish, and seafood, as well as vaccines and biologics. The increasing demand for online grocery delivery and the globalization of markets are driving the growth of this logistics industry. Digitalization and advanced temperature monitoring technologies are transforming the industry, enabling real-time monitoring and automated tracking systems.

How do company ranking index and market positioning come to your aid?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AGRO Merchants Group - The company offers cold chain logistics equipped with conventional, mobile racking, automated storage, and retrieval systems.

Technavio provides the ranking index for the top 14 companies along with insights on the market positioning of:

AP Moller Maersk AS
Andrew Marr International Ltd
Central Insulations Ltd
Chiltern Cold Storage Group Ltd.
Kerry Logistics Network Ltd.
Lineage Logistics Holdings LLC
Magnavale Ltd
NewCold Cooperatief UA
Posten Norge AS
Reed Boardall Cold Storage Ltd.
Seafast Logitics Ltd.
Trade Distribution Ltd
XPO Inc.

Explore our company rankings and market positioning. Request Free Sample

How can Technavio assist you in making critical decisions?

What is the market structure and year-over-year growth of the Market?

Global Healthcare Cold Chain Logistics market size will be USD 21.83 Billion by 2030. Healthcare Cold Chain Logistics Industry's Compound Annual Growth Rate will be 4.19% from 2023 to 2030.